News | May 28, 2025
Granules India posts Q4 FY25 PAT at Rs. 152 Cr
The company reported sustained increase in formulations' share despite slowdown in productivity of Gagillapur facility
The company reported sustained increase in formulations' share despite slowdown in productivity of Gagillapur facility
Lupin is set to become first Indian company to fully integrate Honeywell’s Solstice® Air in its respiratory inhalers at scale, redefining respiratory care with near-zero global warming potential propellants
The Atlan A100 system delivers advanced ventilation technology for adults, pediatric patients, and neonates, revolutionizing care with seamless workflows across hospital departments
Introduces revolutionary approach to workflow management to enhance operational efficiency and optimize process efficiency
Total Income during Q3 FY25 stood at Rs. 527.37 crore as compared to Rs. 528.77 crore in Q3 FY24
This facility is considered to be in a minimally acceptable state of compliance with regard to current GMP
Univar Solutions' pharmaceutical ingredients portfolio will be strengthened by the addition of a broad range of cellulose ethers and other excipient solutions
Expansion includes a new 5-story, 136k sq. ft. multipurpose building in Sejong
ALS patients experience neuroinflammation and rapid neurodegeneration
USFDA has determined that the inspection classification of this facility is "No Action Indicated" (NAI) with zero 483 observation
Subscribe To Our Newsletter & Stay Updated
